NIVFW
NewGenIvf Group Limited WarrantsKey Statistics
About NewGenIvf Group Limited Warrants
NewGenIvf Group Limited Warrants (NIVFW) is a pioneering biotechnology company specializing in assisted reproductive technology (ART) aimed at transforming reproductive healthcare. With a commitment to enhancing fertility success rates and elevating care standards, the firm utilizes advanced research and innovative technologies to address the surging global demand for IVF services. Positioned strategically within the fertility sector, NewGenIvf is poised for significant growth, anticipating strategic partnerships and continuous improvements to optimize patient outcomes in a dynamic marketplace.
Fundamentals
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $308.19 |
| Book Value | $331.51 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 0 |
| Float | 187,370 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NIVFW and any ticker you trade — then tracks every position and per-strategy win rate.